Form 4 for AURA Aura Biosciences, Inc.
Accepted 2025-10-16 00:00:00 ET · period of report 2025-10-16 · accession 0001193125-25-241622 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-16 | 2025-10-16 | AURA | Plavsic Mark | CTO | S - Sale | $6.35 | -12.2K | 197.3K | -6% | -$77.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-16 | S | D | 12,169 | $6.35 | 197,287 | D | — | — |